Changes in Serum Growth Factors during Lenvatinib Predict the Post Progressive Survival in Patients with Unresectable Hepatocellular Carcinoma

SIMPLE SUMMARY: In this study, we firstly revealed that the pattern of developing resistance to lenvatinib varies and determines the prognosis of patients with unresectable hepatocellular carcinoma (HCC) by analyzing the changes in growth factors during lenvatinib for unresctable HCC. The evaluation...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zijian, Suda, Goki, Maehara, Osamu, Ohara, Masatsugu, Yoshida, Sonoe, Hosoda, Shunichi, Kimura, Megumi, Kubo, Akinori, Tokuchi, Yoshimasa, Fu, Qingjie, Yamada, Ren, Kitagataya, Takashi, Suzuki, Kazuharu, Kawagishi, Naoki, Nakai, Masato, Sho, Takuya, Natsuizaka, Mitsuteru, Morikawa, Kenichi, Ogawa, Koji, Ohnishi, Shunsuke, Sakamoto, Naoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750627/
https://www.ncbi.nlm.nih.gov/pubmed/35008398
http://dx.doi.org/10.3390/cancers14010232

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750627/
https://www.ncbi.nlm.nih.gov/pubmed/35008398
http://dx.doi.org/10.3390/cancers14010232

Ejemplares similares